Sorry, another one and i do feel like i am getting a little obsessive on the issue but why don't the incumbent tavr providers need to get FDA approval for ViV? If they don't need it, surely approval for Duravr is also sufficient for this market.
Sorry, another one and i do feel like i am getting a little...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.95 |
Change
0.200(1.01%) |
Mkt cap ! $383.4M | |||
| Open | High | Low | Value | Volume |
| $19.95 | $20.00 | $19.83 | $183.2K | 9.187K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $19.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.95 | 472 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |